A series of experimental reports comparing recurrent and non-recurrent human GBMs have demonstrated the activation of STAT3, a well-defined redox-sensitive transcription factor responsible for the aggressiveness of several tumors including GBM. This evidence concerns the gene STAT3 and glioblastoma.